Shanxian M. Guo

519 Beijing East Road
Nanchang, 330029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Retraction notice to "MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1" [Biomed. Pharmacother. 93 (2017), 1065-1073].

Retraction notice to "MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1" [Biomed. Pharmacother. 93 (2017), 1065-1073].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 06, 2026

Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report.

Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report.

Journal: Frontiers in oncology

Published: February 14, 2024

Vitamin D-mediated tsRNA-07804 triggers mitochondrial dysfunction and suppresses non-small cell lung cancer progression by targeting CRKL.

Vitamin D-mediated tsRNA-07804 triggers mitochondrial dysfunction and suppresses non-small cell lung cancer progression by targeting CRKL.

Journal: Journal of cancer research and clinical oncology

Published: October 30, 2023

Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.

Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.

Journal: Thoracic cancer

Published: December 22, 2022

CircRNA hsa_circ_0087862 Acts as an Oncogene in Non-Small Cell Lung Cancer by Targeting miR-1253/RAB3D Axis.

CircRNA hsa_circ_0087862 Acts as an Oncogene in Non-Small Cell Lung Cancer by Targeting miR-1253/RAB3D Axis.

Journal: OncoTargets and therapy

Published: December 23, 2019

MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.

MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 01, 2017

Tim-3 facilitates osteosarcoma proliferation and metastasis through the NF-κB pathway and epithelial-mesenchymal transition.

Tim-3 facilitates osteosarcoma proliferation and metastasis through the NF-κB pathway and epithelial-mesenchymal transition.

Journal: Genetics and molecular research : GMR

Published: October 06, 2016

Role and clinical significance of Th17/Treg balance in patients with severe exacerbation of hepatitis B

Role and clinical significance of Th17/Treg balance in patients with severe exacerbation of hepatitis B

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: July 30, 2016

Polymorphisms in DNA repair genes of XRCC1, XPA, XPC, XPD and associations with lung cancer risk in Chinese people.

Polymorphisms in DNA repair genes of XRCC1, XPA, XPC, XPD and associations with lung cancer risk in Chinese people.

Journal: Thoracic cancer

Published: August 28, 2013

Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.

Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: July 27, 2013

Screening and identification of lung cancer metastasis-related genes by suppression subtractive hybridization.

Screening and identification of lung cancer metastasis-related genes by suppression subtractive hybridization.

Journal: Thoracic cancer

Published: August 01, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026